http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100686552-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-16 |
| filingDate | 1999-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100686552-B1 |
| titleOfInvention | Inhomogeneous System for Splitting Enantiomeric Mixtures |
| abstract | The present invention is directed to a process for converting an enantiomeric mixture of hydrophobic esters in a biocatalyst-mediated enantioselective manner using a biphasic solvent system. More particularly, the present invention enzymatically processes antiviral compounds such as 2-hydroxymethyl-5- (5-fluorocytocin-1-yl) -1,3-oxathiolane (FTC) and analogs thereof in a heterogeneous reaction system. A method for synthesizing in an intervening enantioselective manner. |
| priorityDate | 1998-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.